Article Details

AMGEN ANNOUNCES RESULTS FROM TWO OPEN LABEL EXTENSION STUDIES OF ...

Retrieved on: 2022-04-27 13:09:48

Tags for this article:

Click the tags to see associated articles and topics

AMGEN ANNOUNCES RESULTS FROM TWO OPEN LABEL EXTENSION STUDIES OF .... View article details on hiswai:

Excerpt

Repatha® is a human monoclonal antibody that inhibits proprotein ... or any collaboration to manufacture therapeutic antibodies against COVID-19), ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up